University of Aberdeen And GW Pharma plc
Lead Participant:
UNIVERSITY OF ABERDEEN
Abstract
To investigate potential synergism between existing chemotherapeutics and novel non-psychoactive phytocannabinoids in a bid to create novel combination therapies for cancer that have fewer side-effects.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| UNIVERSITY OF ABERDEEN | £93,350 | £ 62,545 |
Participant |
||
| UNIVERSITY OF ABERDEEN | ||
| CVR LIMITED |
People |
ORCID iD |